MedTrace Logo

Pilot Trial of Multilingual Support Intervention

NCT04935047 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2023-03-31

No results posted yet for this study

Summary

This is a feasibility study and a pilot trial of a multilingual support intervention with the aim to improve language training for Norwegian refugees by systematically using the participants' primary language to support the learning of the new language. The study is conducted in three Norwegian municipalities with the aim to evaluate feasibility for a full-scale randomised controlled trial. The pilot trial will include at least 30 participants, with two thirds allocated to the treatment group and one third to the control group. The intervention will be implemented as an add on to ordinary classroom settings. The treatment group will receive seven hours multilingual support weekly. The control group will receive the same amount of support, but from a person without multilingual qualifications. The Norwegian Directorate of Integration and Diversity (IMDi) are funding the project and have reviewed the protocol.

Conditions

  • Language

Interventions

OTHER

Multilingual Support

Multilingual Support is a classroom intervention, which is designed to be delivered in classes of adult learning of a new language. The intervention involves the use of a language assistant, who is at minimum independent user (B1) in the language to be learned (in this case Norwegian), according to the language proficiency scale of the Common European Framework of Reference (CEFR) for languages, learning, teaching, assessment (Little, 2006). The language assistant will be in the classroom for seven hours a week, collaborating with the teacher in providing language training. In classrooms where participants have different primary languages, the language assistant(s) must cover all languages represented in the classroom.

Sponsors & Collaborators

  • Oslo Metropolitan University

    lead OTHER

Principal Investigators

  • Anne Grete G Tøge, phd · associate professor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-16
Primary Completion
2022-05-27
Completion
2022-06-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04935047 on ClinicalTrials.gov